The generic Favipiravir in India will be launched in India under the brand name ‘Favivir’, Hetero Labs, part of Hetero group announced on Wednesday
Quoting from a press release issued by the city-based drug maker, The Financial Express reported that the Drug Controller General of India (DCGI) has granted Hetero the manufacturing and marketing approval for Favipiravir.
Favivir is the second drug developed by Hetero after Covifor (Remdesivir) used in the treatment of COVID-19, the report said.
About Favivir
Bhubaneswar: After untimely rains for two consecutive days last week, Odisha is likely to experience…
Hyderabad: PV Sindhu and Venkata Datta Sai are man and wife now. India’s ace shuttler and…
Paradip: Crew members of a cargo ship, which has been berthed at Odisha’s Paradip port…
Bhubaneswar: After a two-day closure due to heavy rainfall, Similipal National Park located in Odisha’s…
Bhubaneswar: The Annual Founder’s Day of SAI International Residential School (SIRS) was celebrated in style,…
Balasore: Tension prevailed at Kamarda Bazar in Odisha’s Balasore district during a crackdown by excise…
This website uses cookies.